Essential Thrombocythemia (ET)
Also known as: ET (Essential Thrombocythemia) / Thrombocythemia Essential / Essential Thrombocytosis / Essential Thrombocythaemia / Essential Thrombocythemia / Thrombocythemia, Essential / Primary hemorrhagic thrombocythemia / Primary haemorrhagic thrombocythaemia / Essential (hemorrhagic) thrombocythemia / Essential thrombocythemia (disorder) / Essential thrombocythemia (morphologic abnormality) / Idiopathic thrombocytosis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01008 | Busulfan | An alkylating agent used to treat chronic myelogenous leukemia. |
| DB01005 | Hydroxyurea | An antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip). |
| DB11697 | Pacritinib | A kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts. |